Belite Bio Shares Down 4.2 percent Should You Sell?
BLTE Stock | USD 58.72 3.37 5.43% |
About 61% of Belite Bio's investor base is looking to short. The analysis of the overall investor sentiment regarding Belite Bio ADR suggests that many traders are alarmed. The current market sentiment, together with Belite Bio's historical and current headlines, can help investors time the market. In addition, many technical investors use Belite Bio ADR stock news signals to limit their universe of possible portfolio assets.
Belite |
Belite Bio, Inc s share price fell 4.2 percent during trading on Friday . The company traded as low as 62.01 and last traded at 62.01. 9,597 shares were traded during trading, a decline of 63 percent from the average session volume of 26,076 shares. The stock had previously closed at 64.76. Analyst
Read at thelincolnianonline.com
Belite Bio Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Belite Bio can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Belite Bio Fundamental Analysis
We analyze Belite Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Belite Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Belite Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Target Price
Target Price Comparative Analysis
Belite Bio is currently under evaluation in target price category among its peers.
Belite Bio ADR Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Belite Bio stock to make a market-neutral strategy. Peer analysis of Belite Bio could also be used in its relative valuation, which is a method of valuing Belite Bio by comparing valuation metrics with similar companies.
Peers
Belite Bio Related Equities
ALGS | Aligos Therapeutics | 5.07 | ||||
ANAB | AnaptysBio | 4.79 | ||||
AADI | Aadi Bioscience | 4.60 | ||||
MOLN | Molecular Partners | 3.90 | ||||
ACRV | Acrivon Therapeutics, | 2.57 | ||||
PMVP | Pmv Pharmaceuticals | 1.29 | ||||
MLYS | Mineralys Therapeutics, | 1.18 | ||||
IMRX | Immuneering Corp | 0.85 | ||||
AVTE | Aerovate Therapeutics | 0.75 | ||||
TRDA | Entrada Therapeutics | 1.42 | ||||
CNTA | Centessa Pharmaceuticals | 1.59 | ||||
VIGL | Vigil Neuroscience | 1.64 | ||||
IKNA | Ikena Oncology | 1.78 | ||||
ANEB | Anebulo Pharmaceuticals | 1.82 | ||||
ADAG | Adagene | 1.98 | ||||
GLTO | Galecto | 2.81 | ||||
ANTX | AN2 Therapeutics | 2.82 | ||||
CELC | Celcuity LLC | 3.30 | ||||
GLUE | Monte Rosa | 3.91 | ||||
LRMR | Larimar Therapeutics | 5.26 |
Complementary Tools for Belite Stock analysis
When running Belite Bio's price analysis, check to measure Belite Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Belite Bio is operating at the current time. Most of Belite Bio's value examination focuses on studying past and present price action to predict the probability of Belite Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Belite Bio's price. Additionally, you may evaluate how the addition of Belite Bio to your portfolios can decrease your overall portfolio volatility.
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Stocks Directory Find actively traded stocks across global markets | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |